Richard D Moore Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2019	Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.
1/2016	Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.
10/2015	Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
6/2014	HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
5/2010	Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Moore Research Topics

Disease

57	Acquired Immunodeficiency Syndrome (AIDS) 11/2023 - 07/2002
27	HIV Infections (HIV Infection) 01/2023 - 01/2002
25	Infections 11/2023 - 01/2002
19	Substance-Related Disorders (Drug Abuse) 11/2023 - 03/2002
17	Coinfection 11/2023 - 08/2003
17	Viremia 10/2023 - 02/2004
15	Neoplasms (Cancer) 11/2023 - 02/2008
9	Hepatitis C 12/2022 - 01/2002
9	Disease Progression 01/2019 - 03/2003
7	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2017
7	Myocardial Infarction 01/2023 - 01/2017
6	Hepatitis 01/2022 - 01/2002
6	Fibrosis (Cirrhosis) 04/2019 - 01/2005
5	Chronic Renal Insufficiency 01/2023 - 09/2012
5	Kidney Diseases (Kidney Disease) 01/2023 - 12/2007
5	Hypertension (High Blood Pressure) 01/2022 - 12/2011
5	Sepsis (Septicemia) 01/2021 - 01/2017
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 05/2010
5	Tuberculosis (Tuberculoses) 01/2017 - 07/2007
5	Syphilis 11/2015 - 06/2008
4	COVID-19 12/2022 - 10/2021
4	Marijuana Use 12/2021 - 01/2017
4	Weight Gain 10/2021 - 01/2016
4	Hepatitis B 01/2021 - 11/2004
4	Obesity 03/2020 - 03/2011
4	Liver Diseases (Liver Disease) 07/2012 - 10/2003
4	Opportunistic Infections (Opportunistic Infection) 08/2011 - 12/2003
3	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 07/2017
3	Opioid-Related Disorders (Opiate Addiction) 11/2023 - 06/2010
3	Anemia 01/2023 - 01/2002
3	Alcoholism (Alcohol Abuse) 01/2022 - 03/2011
3	Inflammation (Inflammations) 01/2017 - 01/2011
3	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017 - 10/2015
3	Overweight 10/2016 - 03/2011
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 10/2003
3	Lymphoma (Lymphomas) 07/2014 - 08/2013
3	Chronic Kidney Failure (Chronic Renal Failure) 09/2013 - 11/2007
3	Mental Disorders (Mental Disorder) 05/2009 - 12/2004
2	Weight Loss (Weight Reduction) 11/2023 - 03/2010
2	Anus Neoplasms (Anal Cancer) 01/2022 - 01/2020
2	End Stage Liver Disease 01/2022 - 07/2012
2	Diabetes Mellitus 10/2021 - 01/2021
2	Ischemic Stroke 01/2021 - 01/2019
2	Stroke (Strokes) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2019
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 01/2017
2	Persistent Infection 10/2017 - 12/2012
2	Bacteremia 01/2017 - 10/2003
2	Immune Reconstitution Inflammatory Syndrome 07/2014 - 12/2007
2	Herpes Zoster 10/2012 - 10/2005

Drug/Important Bio-Agent (IBA)

37	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2002
13	Cocaine (Cocaine HCl)IBA 11/2023 - 03/2002
7	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 03/2006
6	Opioid Analgesics (Opioids)IBA 11/2023 - 06/2010
6	Antiviral Agents (Antivirals)IBA 10/2023 - 11/2006
6	Oxygen (Dioxygen)IBA 01/2023 - 01/2017
5	CholesterolIBA 03/2024 - 01/2011
5	efavirenz (Sustiva)FDA Link 10/2021 - 01/2002
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2020 - 01/2002
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2017
4	Tenofovir (Viread)FDA Link 01/2023 - 02/2008
4	Crack CocaineIBA 01/2022 - 01/2017
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 01/2017
4	Heroin (Diamorphine)IBA 01/2021 - 03/2002
3	Triglycerides (Triacylglycerol)IBA 03/2024 - 03/2020
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2008
3	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2002
3	LipidsIBA 01/2023 - 11/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 01/2011
3	InterferonsIBA 12/2022 - 01/2017
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 02/2008
3	Integrase InhibitorsIBA 10/2021 - 01/2020
3	Raltegravir Potassium FDA Link 10/2021 - 01/2014
3	abacavir (Ziagen)FDA Link 01/2021 - 02/2008
3	N-acetoacetyl-N-deacetylcolchicineIBA 05/2020 - 02/2008
3	AntigensIBA 01/2020 - 11/2015
3	Reverse Transcriptase InhibitorsIBA 01/2020 - 08/2003
3	NucleosidesIBA 01/2020 - 02/2004
2	Interleukin-18 (Interleukin 18)IBA 12/2023 - 01/2017
2	Immunoglobulin G (IgG)IBA 11/2023 - 01/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2021
2	CreatinineIBA 01/2023 - 07/2017
2	N-nitrosoiminodiacetic acidIBA 12/2022 - 12/2022
2	BilirubinIBA 01/2022 - 01/2019
2	Serum AlbuminIBA 01/2022 - 02/2006
2	Darunavir (Prezista)FDA Link 01/2022 - 01/2021
2	IntegrasesIBA 10/2021 - 01/2021
2	dolutegravirIBA 10/2021 - 01/2021
2	Emtricitabine (Emtriva)FDA Link 01/2021 - 06/2017
2	Viral RNAIBA 01/2019 - 01/2017
2	insulin receptor-related receptor (IRR)IBA 04/2015 - 10/2003
2	Alanine Transaminase (SGPT)IBA 12/2014 - 03/2014
2	Indicators and Reagents (Reagents)IBA 01/2014 - 10/2003
2	CI 22IBA 10/2013 - 12/2012

Therapy/Procedure

68	Therapeutics 11/2023 - 01/2002
44	Highly Active Antiretroviral Therapy (HAART) 10/2021 - 01/2002
40	Art Therapy 01/2023 - 11/2004
7	Retention in Care 10/2022 - 06/2012
5	Continuity of Patient Care 01/2021 - 01/2016
3	Critical Care (Surgical Intensive Care) 01/2022 - 10/2003